Sickle cell disease and COVID-19: Susceptibility and severity겸상적혈구병 및 COVID-19: 감수성 및 중증도Review Published on 2021-08-012022-09-11 Journal: Pediatric blood & cancer [Category] SARS, 치료기술, [키워드] Admission Adults age benefit Cell children Clinical course Comorbidity coronavirus disease Coronavirus disease 2019 COVID-19 detect determinants disease explain General population HbF Health hydroxyurea Hypercoagulation intensive care International Mild moderate Older organ damage outcome Patient patients pediatric registry SCD severe COVID-19 severity sickle cell Sickle cell disease splenectomy susceptibility therapy [DOI] 10.1002/pbc.29075 PMC 바로가기 [Article Type] Review